Table 2. Factors associated with starting antidepressant medication treatment (N=158).
The odds ratios are derived from a pooled unweighted logistic regression model fit on the subsample of person-visits for which no exposure to antidepressant medication had yet occurred through the prior visit.
Adjusted odds ratio (95% CI) | Wald P-value | |
---|---|---|
Baseline age (years) | 1.01 (0.96–1.07) | 0.64 |
Sex (female) | 0.29 (0.10–0.86) | 0.03 |
Education | ||
No diploma | Ref | |
High school graduate | 0.91 (0.31–2.66) | 0.87 |
Some college or more | 2.21 (0.66–7.45) | 0.20 |
Race | ||
Other | Ref | |
White | 0.29 (0.10–0.84) | 0.02 |
Black | 0.34 (0.12–0.97) | 0.04 |
Any chronic illness | 7.35 (2.71–19.9) | <0.001 |
CD4+ T-lymphocyte cell count nadir | 0.99 (0.99–1.00) | 0.12 |
Beck Depression Inventory-II score at baseline | 1.02 (0.99–1.06) | 0.24 |
Beck Depression Inventory-II score at prior visit | 1.04 (1.01–1.08) | 0.02 |
Cumulative days of follow up | 0.99 (0.99–1.00) | 0.73 |